Hemopatch (Baxter) and Tachosil (Takeda) are the Key Players in the European Hemostats & Sealants Market

PUNE, India, 2021-Apr-13 — /EPR Network/ —

The European hemostats and sealants (focused brands) market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%. Growth in this market is mainly driven by the favorable reimbursement scenario for the usage of hemostats in various surgeries. However, the shift towards minimally invasive surgeries over open surgeries is a major restraint for this market.

Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

The market for hemostats and sealants is anticipated to grow mainly due to the launch of the new products, M&A’s, and favorable reimbursement scenario in Europe. However, the increasing preference for minimally invasive surgeries and the reducing preference for the usage of hemostats while performing surgeries are expected to hinder the growth of this market during the forecast year. Leading players operating in this market are Ethicon (J&J), Baxter, Pfizer, Baxter, C. R. Bard, and B. Braun.

Focused brands for this study are Hemopatch (Baxter), Tachosil (Takeda), Veriset (Medtronic), Avitene (C. R. Bard), and Sangustop & Lyostypt (B Braun).

Key questions addressed in the report:

What are the growth opportunities in the hemostats and sealants market across major countries in Europe in the future?
What are the key drivers and restraints in the hemostats and sealants market?
What are the key brands in the hemostats and sealants market?
Which are the key countries in the hemostats and sealants market?
What are the most preferred brands amongst end users?

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com